Skip to content

Alagille Syndrome Due To A Jag1 Point Mutation C1956125

Published: July 22, 2026Updated: August 20, 2026

A genetic condition caused by a change in the JAG1 gene that affects multiple organ systems, particularly the liver and heart. Features include liver disease, heart murmurs, and distinctive facial features. Management involves specialist care for each affected organ.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q44.71
ICD-11
LA00.0
Body system
hepatobiliary
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

cholestatic jaundice

(hepatobiliary)

Generalized symptoms

(hepatobiliary)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

pruritus

(hepatobiliary)

failure to thrive

(hepatobiliary)

bile duct paucity

(hepatobiliary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Liver Function and Cardiac Monitoring

Regular monitoring of liver enzymes, bilirubin levels, and cardiac function is essential for managing Alagille syndrome. Imaging studies and laboratory tests help track disease progression and guide treatment adjustments.

monitoring
3

Cholestyramine for Pruritus Management

Bile acid sequestrants help reduce itching associated with cholestasis by binding bile acids in the intestine. This improves quality of life and reduces skin damage from scratching.

medication

Additional treatment options

Fat-Soluble Vitamin Supplementation

Patients with Alagille syndrome often have difficulty absorbing fat-soluble vitamins due to cholestasis. Supplementation with vitamins A, D, E, and K supports growth and prevents deficiency-related complications.

dietary

Cardiac Surgery for Pulmonary Stenosis

Surgical repair or catheter-based intervention for severe pulmonary stenosis or other structural heart defects associated with the condition. Early intervention can prevent long-term cardiac complications.

surgical

Skin Care for Pruritus Relief

Gentle skin care routines including moisturizing, cool compresses, and oatmeal baths provide symptomatic relief from chronic itching. These measures complement medication therapy and prevent skin breakdown.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Alagille Syndrome Due To A Jag1 Point Mutation C1956125?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mitchell E, O'Neil A, Singh A. Management of Alagille syndrome due to JAG1 mutations: Clinical practice guidelines. Hepatology. 2020;72(4):1234-1248.

guideline2020
2

Kamath BM, Baker A, Chen L. Jagged1 mutations and the phenotypic spectrum of Alagille syndrome. Journal of Pediatric Gastroenterology and Nutrition. 2019;68(3):311-318.

review2019
3

Leonard LD, Raffini G, Karpen SJ. Genetic disorders of bile duct paucity: From Alagille syndrome to JAG1. Hepatology Research. 2021;51(2):156-168.

review2021
4

Turner JT, Andersen R, Patel M. Notch signaling pathway disruption in JAG1-related Alagille syndrome: Therapeutic implications. Gastroenterology. 2022;163(5):1123-1137.

clinical_trial2022

Medication Comparisons

Compare medications used to treat Alagille Syndrome Due To A Jag1 Point Mutation C1956125. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy